Breaking News

Pharma Technology Appoints Lead Engineer

January 10, 2013

Opens North American HQ

Pharma Technology Inc. (PTI) has retained the services of Chris Hofman as its Support Specialist in North America. Mr. Hofman will be responsible for the company’s expanded capabilities in North America, overseeing installation, start-up, training, calibration validation for PTI’s tablet presses, dedusters and metal detection systems, as well as servicing and troubleshooting. As part of his consulting role, Mr. Hofman will advise PTI’s new and existing customers on potential improvements to manufacturing processes, including formulation, tableting, coating, granulation and fluid bed technologies.
PTI recently opened headquarters in New Jersey to establish a presence in North America to service all new and existing customers in the U.S., Canada and Puerto Rico with spare parts and equipment maintenance programs. It also will serve as the exclusive distributor of the FlexiTab single station R&D tablet press from Germany-based manufacturer Roeltgen.
Mr. Hofman has 20 years of experience having worked for the pharmaceutical industry in R&D and manufacturing positions, as well as field service specialist roles at leading manufacturing equipment specialists. Most recently, he spent four years as a service engineer with OYSTAR North America, an engineering consultant for Sage Engineering, and earlier in his career, held process and production positions with Apotex Pharmaceuticals and TorPharm. 
“Bringing a specialist with Chris’ credentials and experience onto our U.S. team is the next step in cementing Pharma Technology Inc.’s footprint in North America,” said Nic Michel, general manager, North America for Pharma Technology Inc.  “Chris will be the focal point of a service team that provides North American pharmaceutical companies with efficient, expert service for our wide range of dedusters, tablet presses and ancillary equipment.”

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks